| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 3
| Issue : 2 | Page : 74-78 |
|
|
Cardiac stem cell therapy: Current status
Sridharan Umapathy
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Sridharan Umapathy
Department of Cardiology, AIIMS, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpcs.jpcs_12_17
|
|
|
Cardiac injury due to any cause leads to cardiac cell damage and thereby to ventricular dysfunction. Unlike current medical therapy, cardiac regeneration by stem cell therapy is a promising approach which has a potential to reverse left ventricular dysfunction. It is conceived to complement and potentially transform available therapeutic armamentarium. Early experience in clinical studies support the safety and feasibility of cell therapy and as adjuvants to established practice. This review discusses type of stem cells used, its therapeutic indications, and its current status.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
